Terms: = Lung cancer AND RAD21, HR21, 5885, ENSG00000164754, KIAA0078, FLJ25655, hHR21, MCD1, O60216, NXP1, HRAD21, FLJ40596, SCC1
22 results:
1. NIPBL-mediated rad21 facilitates tumorigenicity by the PI3K pathway in non-small-cell lung cancer.
Xu X; Wang D; Xu W; Li H; Chen N; Li N; Yao Q; Chen W; Zhong J; Mao W
Commun Biol; 2024 Feb; 7(1):206. PubMed ID: 38378967
[TBL] [Abstract] [Full Text] [Related]
2. Hexavalent Chromium Targets Securin to Drive Numerical Chromosome Instability in Human lung Cells.
Toyoda JH; Martino J; Speer RM; Meaza I; Lu H; Williams AR; Bolt AM; Kouokam JC; Aboueissa AE; Wise JP
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203427
[TBL] [Abstract] [Full Text] [Related]
3. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.
Kinnaman MD; Zaccaria S; Makohon-Moore A; Arnold B; Levine MF; Gundem G; Arango Ossa JE; Glodzik D; Rodríguez-Sánchez MI; Bouvier N; Li S; Stockfisch E; Dunigan M; Cobbs C; Bhanot UK; You D; Mullen K; Melchor JP; Ortiz MV; O'Donohue TJ; Slotkin EK; Wexler LH; Dela Cruz FS; Hameed MR; Glade Bender JL; Tap WD; Meyers PA; Papaemmanuil E; Kung AL; Iacobuzio-Donahue CA
Cancer Res; 2023 Nov; 83(22):3796-3812. PubMed ID: 37812025
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic score for synchronous metastatic rectal cancer: A real-world study.
Muzellec L; Campion L; Bachet JB; Taieb J; Fremont E; Senellart H; Moreau J; Bouché O; Garric M; Guimbaud R; Greilsamer C; Bodère A; Lièvre A; Girot P; Edeline J; Tougeron D; Bennouna J; Touchefeu Y
Dig Liver Dis; 2023 Oct; 55(10):1411-1416. PubMed ID: 37005173
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Significance of Serum Biomarkers in Stage IV Non-Small-Cell lung cancer Treated with PD-1 Inhibitors: LIPI Score, NLR, dNLR, LMR, and PAB.
Chen J; Wei S; Zhao T; Zhang X; Wang Y; Zhang X
Dis Markers; 2022; 2022():7137357. PubMed ID: 35945957
[TBL] [Abstract] [Full Text] [Related]
6. Possible Molecular Mechanisms for the Roles of MicroRNA-21 Played in lung cancer.
Wang Q; Zhang L
Technol Cancer Res Treat; 2019 Jan; 18():1533033819875130. PubMed ID: 31506038
[TBL] [Abstract] [Full Text] [Related]
7. Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer.
Nakajima K; Iwata H; Ogino H; Hattori Y; Hashimoto S; Toshito T; Hayashi K; Akita K; Baba F; Nakamae K; Mizoe JE; Shibamoto Y
Radiat Oncol; 2018 Oct; 13(1):199. PubMed ID: 30305125
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of optical imaging agents in a fluorescence-guided surgical model of head and neck cancer.
Prince AC; Moore LS; Tipirneni KE; Ramesh T; Limdi MA; Bevans SL; Walsh EM; Greene B; Rosenthal EL; Warram JM
Surg Oncol; 2018 Jun; 27(2):225-230. PubMed ID: 29937175
[TBL] [Abstract] [Full Text] [Related]
9. Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
Iida M; Bahrar H; Brand TM; Pearson HE; Coan JP; Orbuch RA; Flanigan BG; Swick AD; Prabakaran PJ; Lantto J; Horak ID; Kragh M; Salgia R; Kimple RJ; Wheeler DL
Mol Cancer Ther; 2016 Sep; 15(9):2175-86. PubMed ID: 27422810
[TBL] [Abstract] [Full Text] [Related]
10. The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer.
Zhao J; Fu W; Liao H; Dai L; Jiang Z; Pan Y; Huang H; Mo Y; Li S; Yang G; Yin J
BMC Cancer; 2015 Oct; 15():731. PubMed ID: 26482648
[TBL] [Abstract] [Full Text] [Related]
11. Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial.
Jamal-Hanjani M; A'Hern R; Birkbak NJ; Gorman P; Grönroos E; Ngang S; Nicola P; Rahman L; Thanopoulou E; Kelly G; Ellis P; Barrett-Lee P; Johnston SR; Bliss J; Roylance R; Swanton C
Ann Oncol; 2015 Jul; 26(7):1340-6. PubMed ID: 26003169
[TBL] [Abstract] [Full Text] [Related]
12. Enhancement of radiation response with bevacizumab.
Hoang T; Huang S; Armstrong E; Eickhoff JC; Harari PM
J Exp Clin Cancer Res; 2012 Apr; 31(1):37. PubMed ID: 22538017
[TBL] [Abstract] [Full Text] [Related]
13. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
[TBL] [Abstract] [Full Text] [Related]
14. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer.
Lecharpentier A; Vielh P; Perez-Moreno P; Planchard D; Soria JC; Farace F
Br J Cancer; 2011 Oct; 105(9):1338-41. PubMed ID: 21970878
[TBL] [Abstract] [Full Text] [Related]
15. Cetuximab augments cytotoxicity with poly (adp-ribose) polymerase inhibition in head and neck cancer.
Nowsheen S; Bonner JA; Lobuglio AF; Trummell H; Whitley AC; Dobelbower MC; Yang ES
PLoS One; 2011; 6(8):e24148. PubMed ID: 21912620
[TBL] [Abstract] [Full Text] [Related]
16. Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers.
Mita Y; Yasuda Y; Sakai A; Yamamoto H; Toyooka S; Gunduz M; Tanabe S; Naomoto Y; Ouchida M; Shimizu K
J Cancer Res Clin Oncol; 2010 Feb; 136(2):249-59. PubMed ID: 19672627
[TBL] [Abstract] [Full Text] [Related]
17. Malignant pleural mesothelioma: genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets.
Røe OD; Anderssen E; Sandeck H; Christensen T; Larsson E; Lundgren S
Lung Cancer; 2010 Jan; 67(1):57-68. PubMed ID: 19380173
[TBL] [Abstract] [Full Text] [Related]
18. Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer.
Kruser TJ; Armstrong EA; Ghia AJ; Huang S; Wheeler DL; Radinsky R; Freeman DJ; Harari PM
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):534-42. PubMed ID: 18793955
[TBL] [Abstract] [Full Text] [Related]
19. Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer.
Lesueur F; Pharoah PD; Laing S; Ahmed S; Jordan C; Smith PL; Luben R; Wareham NJ; Easton DF; Dunning AM; Ponder BA
Hum Mol Genet; 2005 Aug; 14(16):2349-56. PubMed ID: 16000320
[TBL] [Abstract] [Full Text] [Related]
20. Gene expression dose-response changes in microarrays after exposure of human peripheral lung epithelial cells to nickel(II).
Cheng RY; Zhao A; Alvord WG; Powell DA; Bare RM; Masuda A; Takahashi T; Anderson LM; Kasprzak KS
Toxicol Appl Pharmacol; 2003 Aug; 191(1):22-39. PubMed ID: 12915101
[TBL] [Abstract] [Full Text] [Related]
[Next]
